Table 1.
Demographics and clinical signs at hospital admission in patients overalla
| Variables | N = 41 | |
|---|---|---|
| Female, (%) | 18 (43.9) | |
| Age,(years) | 45 (31,53) | |
| Temperature,(°C) | 37.2 (36.6,38.0) | |
| Oxygen saturation, (%) | 97 (95,99) | |
| Travel/Contact history, (%) | ||
| Wuhan | 4 (9.8) | |
| Wuhan-related | 28 (68.3) | |
| Beijing | 4 (9.8) | |
| Thailand | 5 (12.2) | |
| Underlying Diseases | ||
| Hypertension, (%) | 7 (17.1) | |
| Diabetes, (%) | 3 (7.3) | |
| COPD, (%) | 2 (4.9) | |
| Coronary heart disease, (%) | 1 (2.4) | |
| HBV/HCV Infection | 0 | |
| Laboratory results | Normal range | |
| Lymphocyte percentage, (%) | 23.91 ± 9.90 | 20–40 |
| Lymphocyte count,(10^9/L) | 1.29 ± 0.63 | 1.1–1.32 |
| CRP,(mg/L) | 11.3 (2.45,35.2) | 0–6 |
| LDH,(U/L) | 226.15 ± 59.67 | 109–245 |
| CK,(U/L) | 78.0 (56.5138.0) | 26–174 |
| CK-MB,(U/L) | 17.0 (12.0,24.5) | 0–24 |
| cTnI,(ng/mL) | 1.5 (0.8,5.0) | 0–0.5 |
| Myoglobin,(mg/mL) | 26.0 (19.7118.6) | 0–85 |
| AST,(U/L) | 26.0 (21.0,34.0) | 8–40 |
| ALT,(U/L) | 27.0 (19.3,46.5) | 5–40 |
| WBC,(10^9/L) | 5.42 ± 1.73 | 3.5–9.5 |
| ECG, (%) | ||
| Normal | 9 (22) | |
| Abnormal | 31 (78) | |
| Lung imagings, (%) | ||
| Nonpneumonia | 5 (12.2) | |
| Pneumonia | 36 (87.8) | |
|
Bilateral GGO & Consolidation &Pleural effusion Unilateral GGO & Consolidation |
27 (65.8)9 (22) | |
| Group, (%) | ||
| Mild | 5 (12.2) | |
| Moderate | 28 (68.3) | |
| Severe | 8 (19.5) | |
| Oxygen Therapy, (%) | 32 (78) | |
| The numbers of “day of illness” at admission,(days) | 4.29 ± 1.4 | |
aReported as means and standard deviations or medians and interquartile ranges for continuous variables, and reported as number and percentage for categorical variables
ALT alanine aminotransferase; AST aspartate aminotransferase; CK creatine kinase; CK-MB creatine kinase-myocardial band; CRP c-reactive protein; cTnI cardiac troponin-I; LDH lactate dehydrogenase;WBC white blood cell count; ECG electrocardiograph; HBV, hepatitis B Virus; HCV, hepatitis C Virus;COPD, chronic obstructive pulmonary disease